The diabetes drug metformin (Glucophage) reduced the risk of death by 36% over 10.7 years in Type 2 diabetics according to a 1998 study.

Metformin ALONE was the ONLY diabetes drug to reduce the risk of death.

Adding the diabetes drug metformin (Glucophage) to Type 2 diabetics who were already taking a sulphonylurea DOUBLED the risk of diabetes-related death—a 96% increase—over 10.7 years compared with continued sulphonylurea alone according to a 1998 study.

Metformin ALONE was the ONLY diabetes drug to reduce the risk of death.

Overweight patients given 20 mg of Prozac (fluoxetine) per day plus 500 mg of the anti-diabetes drug metformin (Glucophage) given three times per day lost an average of 17.4 pounds after six-and-a-half months compared to 1.1 pounds for those not taking the medication according to a new study from Iran.

Type 2 diabetics taking metformin (Glucophage) and Topamax (topiramate) lost 4.5 to 6.5 percent of their body weight after one year compared to 1.7 percent for those taking only metformin (Glucophage) according to a large study from the Medical University in Graz, Austria.

Glucophage (metformin) causes a small amount of weight loss on the order of a couple of pounds when given to patients with diabetes. However, it appears to considerably reduce the risk of diabetes related diseases and death compare to other diabetes treatments according to a new review.

When considering only patients who lose at 5 percent of their body weight by the end of weight loss studies, diet and lifestyle changes cause an average weight loss of less than 11 pounds after 2-4 years; weight loss medications cause an average weight loss of 11 to 22 pounds after 1-2 years; and weight loss surgery causes an average weight loss of 55-165 pounds after 2-4 years according to a new review from researchers at McMaster University in Ontario, Canada.

Obese women with polycystic ovary syndrome (PCOS) lost an average of 4.6 pounds more when given a 2250 mg of Glucophage (metformin) compared with 1500 mg per day according to a new study from Glasgow, Scotland.

Being overweight increases the risk of type 2 diabetes more than any other disease. Xenical (orlistat) reduces the risk of diabetes over a two-to-four year period by 37 percent according to paper from Canada.

Precose (acarbose) caused more weight loss than Glucophage (metformin) in type 2 diabetics according to a recent study.

SOME STUDIES HAVE SHOWN that type II diabetics lose small amounts of weight using the drug metformin (Glucophage). However combining metformin with glyburide (Micronase) worked significantly better than either one alone according to a recent study.